US Medicare Pricing Policies Could Drive Global Costs and Hinder Access Worldwide, Lancet Study Suggests

Health Policy Watch · 4 hours ago

A new modelling study suggests that US Medicare “Most-Favored-Nation” policies on drug prices would cut Medicare spending on brand name drugs, but potentially

Continue reading at Health Policy Watch →

Share this story

Related Reading

ACC Submits Comments on 2027 Medicare Physician Fee Schedule Proposed Rule · American College of Cardiology · 46m ago
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year? · Yahoo Finance · 51m ago
What to Do If Your Medicare Advantage Plan Denies Rehab · ElderLawAnswers · 1h ago
More Details Emerge About Changes In Medicare Plans And Policies · Forbes · 1h ago
Shelter dog visits Pollock nursing home as part of new outreach program · KALB | News Channel 5 · 1h ago
Zocdoc for chatbots and what’s new with Medicare’s ACCESS · STAT · 1h ago